Default company panoramic image
Logo

Lead Horse Technologies, Inc.

Plug-n-play platform uses A.I. pattern recognition algorithm to identify patients at risk for adverse drug events at the point of care.

  • Stage Full Product Ready
  • Industry Healthcare Services
  • Location Junction City, KS, USA
  • Currency USD
  • Employees 6
  • Website leadhorsetech.com

Company Summary

Lead Horse is a health IT company marketing the Medloom clinical decision support system to hospitals, pharmacies, and others in a Software-as-a-Service (SaaS) model. Medloom bolts onto any electronic health information system to help clinicians prevent and treat adverse drug reactions (ADRs) and reduce their associated costs. Its embedded A.I. and other technologies provide real-world, personalized, safety surveillance that is game-changing.

Team

  • Default avatar
    Tage Tracy, CPA
    CFO

    Tage Tracy, CPA, is the company’s part-time CFO. Mr. Tracy is the author of all of the Company’s pro-forma projections and financial statements. Mr. Tracy has taken multiple companies to exit through acquisition and has co-authored well-known accounting books, including How to Manage Profit & Cash Flow: Mining the Numbers for Gold, published by John Wiley & Sons in 2004. Mr. Tracy is also a twice-over investor in Lead Horse.

  • Default avatar
    John M. Armstrong, Ph.D.
    Chairman, CEO & Co-founder

    Dr. Armstrong is an immunologist with experience on bioinformatics executive teams (SVP and CSO) and in big Pharma (Principle Clinical Scientist). He is also the Company’s evangelist. He also partnered with Northrop Grumman IT (NGIT) to win a $29 million bioinformatics project in which he was the lead scientist. NGIT’s project officer for that partnership, Kevin Biersack, is now Lead Horse Tech’s VP of Product Development.

  • Default avatar
    Ramona (Ramie) Leibnitz, Ph.D.
    President & Co-founder

    Dr. Leibnitz is an immunologist and has 25 years in immunology and medical education (NIH, Basel Institute for Immunology, Univ. of Maryland, College Park). She has been on the executive teams of two other medical information companies besides Lead Horse Technologies. She is an experienced medical information architect, and is co-founder of Popular Immunology e-Magazine. Dr. Leibnitz is the science and operations lead for the company.

  • Default avatar
    Kevin Biersack, MBA
    VP of Product Development

    Kevin Biersack, MBA, is the company’s part-time VP of Product Development. Mr. Biersack has 26 years of IT experience, most recently including 16 years with Northrop Grumman specializing in web-enabled, client/server, and mainframe technology. His primary emphasis at NGIT was in health care. Mr. Biersack and Dr. Armstrong worked together before the Company was founded to successfully win a $29 million contract from NIH for Northrop Grumman IT.

  • Default avatar
    Jason Arcediano
    VP of Sales, Strategic Alliances, and Business Development

    Jason Arcediano is the company’s VP of Sales, BD, and Strategic Alliances. He has over 20 years of responsibility for marketing, sales, corporate and business development at Life Science and BioPharm companies working both domestically and internationally. He has worked closely with the FDA and has been lead on teams for several government contracts (DARPA, HHS), while negotiating and developing strategic partnerships and alliances.

  • Default avatar
    Lauren Flanagan
    Strategic Business Advisor

    Lauren is an extrememly active superangel. She is the Managing Director of Detroit-based, Belle Capital, a BusinessWeek Top 25 Tech Investor, and as of August 2011, an investor in Lead Horse Technologies. Lauren is working to add world class luminaries in Health IT to our board and turn Medloom into a global brand. Her Bio can be found at http://www.phenomenelleangels.com/Lauren-Flanagan.html.

Advisors

  • Default avatar
    Morrison & Foerster, LLC
    Lawyer
    Unconfirmed
    Default avatar
    Pottberg, Gassman, and Hoffman, Chartered
    Accountant
    Unconfirmed

Previous Investors

  • Default avatar
    Junction City, Kansas EDC; Heartland Bioventures KBA
    Unconfirmed
    Default avatar
    Women's Capital Connection of Kansas City
    Unconfirmed
    Default avatar
    Angel Capital Group of Nashville
    Unconfirmed